-
2024-517749-15-00
11
Postoperative critical care
-
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
-
2025-521437-88-00
4
head and neck squamous cell carcinoma
-
2025-522996-27-00
5
2026-05-05
recurrent and/or metastatic squamous cell carcinoma of the head and ne
-
2024-511855-16-00
5
2019-07-25
Onco-hematology
-
2024-517325-43-00
4
2025-06-19
multiple myeloma
-
2023-503645-63-00
5
2024-04-25
Patients aged 65 years or older, hospitalized in a non-ICU ward for a
-
2022-502113-28-00
5
2024-02-01
Follicular lymphoma
-
2023-504618-31-00
5
2023-10-20
Chemotherapy induced peripheral neuropathy (CIPN)
-
2024-513669-38-00
5
2023-05-17
Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial In
-
2024-514094-22-00
5
2019-01-18
Intrecerebral Haemorrhage
-
2022-501217-31-00
10
2023-03-09
Hepatocellular carcinoma
-
2022-501179-23-00
6
2023-03-08
atopic dermatitis
-
2024-516168-27-00
5
2022-11-10
Adult patients with persistent or chronic immune thrombocytopenia
-
2024-516403-16-00
5
2022-04-07
Adult patients with immune thrombocytopenia (ITP) with mild to severe
-
2024-513964-24-00
5
2017-09-14
Squamous cell carcinoma, previously untreated
Stage III, stage IVa (op
-
2024-513976-16-00
5
2015-06-26
squamous cell carcinomas of the larynx or hypopharynx locally advance
-
2023-510559-41-00
4
2025-01-02
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
-
2024-514117-35-00
11
2023-01-10
hemorrhoidal disease
-
2024-515356-21-00
5
2018-04-17
Adult subject (18 years of age older) with low or intermediate-1 IPSS
-
2024-512037-32-00
5
2017-05-31
Bartonellosis